Journal article
Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity
LE Downie, KM Hatzopoulos, MJ Pianta, AJ Vingrys, JL Wilkinson-Berka, M Kalloniatis, EL Fletcher
Journal of Comparative Neurology | Published : 2010
DOI: 10.1002/cne.22205
Abstract
Retinopathy of prematurity (ROP) is characterized by deficits in the scotopic pathway, although the cellular locus for these deficits is not clear. Here we examined neurochemical and cellular changes that develop during oxygen-induced retinopathy, a model of ROP. In addition, we examined whether treatment with the angiotensin II type-1 receptor inhibitor, valsartan, prevented these changes. Newborn Sprague-Dawley rats were exposed from postnatal day (P) 0 to 11 to 80%:20% O2 (22:2 hr/day) and then room air until P18. Valsartan (40 mg/kg/day) was administered from P12-P18. Pattern recognition analysis of overlapping amino acid profiles was used to provide a statistically robust and spatially ..
View full abstractRelated Projects (3)
Grants
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Funding Acknowledgements
National Health and Medical Research Council of Australia (NHMRC); Grant numbers: 350434 (to E.L.F.), 350224 (to A.J.V.), 299974 (to J.W-B., E.L.F.); Grant sponsor: NHMRC Senior Research Fellow B (to J.W-B.).